2026-09-292026-09-29https://scholars.csmu.edu.tw/handle/123456789/19409Bladder cancer is the second predilection urinary system cancer, and is a highly metastatic cancer. The recurrent rate of bladder cancer is 70%. The outcome of present clinical treatment of bladde...(詳)胱癌為泌尿系統常見的惡性腫瘤之一，發生率的排名於男性為第七位、女性為第十一位；死亡率的排行於男性為第十一位、女性為第十二位，男性多於女性，男女比約2.5到3比1。目前的治療方針對於膀胱癌是略顯...(詳)桑葚萃取物紫杉醇放射線膀胱癌純化mulberry water extractpaclitaxelIRpurificationbladder cancerProject